Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to administer a combined oral contraceptive (ethinyl estradiol
and norgestimate) with the HIV treatment of atazanavir and ritonavir to healthy females in
order to assess if the concentrations of the oral contraceptive change. The safety of this
treatment regimen will also be studied.